Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Dowlais Group (DWL) by Jefferies
- Buy Norcros (NXR) by Berenberg
- Buy Volex (VLX) by Tom Winnifrith in ShareProphets
- Buy Volex (VLX) by Steve Moore in ShareProphets
- Buy Origin Enterprises (CDI) (OGN) by Shore Capital
- Buy Victorian Plumbing Group (VIC) by Shore Capital
- Avoid Cropper (James) (CRPR) by Steve Moore in ShareProphets
- Buy Close Brothers Group (CBG) by Shore Capital
- Buy WH Smith (SMWH) by Canaccord Genuity
- Hold Halma (HLMA) by Shore Capital
- Buy Speedy Hire (SDY) by Canaccord Genuity
- Buy Norcros (NXR) by Shore Capital
- Buy XPS Pensions Group (XPS) by Canaccord Genuity
- Hold CMC Markets (CMCX) by Shore Capital
- Hold Warehouse Reit (WHR) by Shore Capital
- Buy Jet2 (JET2) by Canaccord Genuity
- Underperform Halma (HLMA) by Jefferies
- Avoid Churchill China (CHH) by Steve Moore in ShareProphets
- Buy Sage Group (SGE) by Bank of America
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 23 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 5.00p | Latest Ask : 5.50p |
| High Today : 5.33p | Low Today : 5.03p |
| This Years High : 6.00p | This Years Low : 1.73p |
| Volume : 117,613 | MKT Cap : £247.83M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-27 14:40:00 27/08/2024 | -30.00% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -126.09% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -116.67% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -30.00% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 67.50% |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 5.00p | Latest Ask : 5.50p |
| High Today : 5.33p | Low Today : 5.03p |
| This Years High : 6.00p | This Years Low : 1.73p |
| Volume : 117,613 | MKT Cap : £247.83M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-27 14:40:00 27/08/2024 | -30.00% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -126.09% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -116.67% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -30.00% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 67.50% |